CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 8-K/A Event Exhibits
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Agreement ended
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Other acquisition Director acquired 9,044 shares (other)
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Grant or award Director acquired 187,804 shares (grant or award)
- 4 Grant or award Director acquired 187,804 shares (grant or award)
- 8-K Event Material agreement · Acquisition or sale completed · Executive or director change
- 4 Grant or award Director acquired 187,804 shares (grant or award)
- 4 Grant or award Director acquired 187,804 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 800,000 shares (grant or award)
- 4 Grant or award Director acquired 6,500 shares (grant or award)
- 4 Grant or award Director acquired 6,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 55,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Agreement ended · Executive or director change
Page 15 of 46 · 907 filings